Skip to main content
SpringerLink
Log in

Basis for the Treatment of Hypertension: Some Considerations Concerning the Epidemiology, Pathophysiology, Treatment, and Prevention of Hypertension

  • Chapter
Book cover Pharmacology of Antihypertensive Therapeutics

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 93 / 1))

  • 161 Accesses

Abstract

Hypertension is a worldwide health problem. Its prevalence is between 10% and 20% of the population. These figures vary depending on the level of blood pressure at which a person is classified as hypertensive and on the technical procedures of blood pressure measurement. Hypertension occurs more frequently in European countries, Japan, and North America than in less industrialized countries and rural societies. It is generally anticipated that the prevalence of hypertension will increase if no specific measures with respect of prevention or improved treatment are taken.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Antonaccio MJ (ed) (1984) Cardiovascular Pharmacology. Raven, New York

    Google Scholar 

  • Bevan AT, Honour AJ, Stott FH (1969) Direct arterial pressure recording in unrestricted man. Clin Sci 36: 329–344

    PubMed  CAS  Google Scholar 

  • Blaustein MP (1980) How does sodium cause hypertension? A hypothesis. In: Zumkley H, Losse H (eds) Intracellular electrolytes and arterial hypertension. Thieme, Stuttgart; pp 151–157

    Google Scholar 

  • Borst JGG, Borst De Geus A (1963) hypertension explained by Starling’s theory of circulatory homeostasis. Lancet i: 677–682

    Google Scholar 

  • Camussi A, Bianchi G (1988) Genetics of essential hypertension. From the unimodalbimodal controversy to molecular technology. Hypertension 12: 620–628

    PubMed  CAS  Google Scholar 

  • Coleman TG, Granger HJ, Guyton AC (1971) Whole body circulatory autoregulation and hypertension. Circ Res 28–29 [Suppl II]: 76–86

    Google Scholar 

  • Conway J (1963) A vascular abnormality in hypertension. A study of blood flow in the forearm. Circulation 27: 520–529

    PubMed  CAS  Google Scholar 

  • Dahl LK, Heine M, Thompson K (1974) Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ Res 34: 94–101

    Google Scholar 

  • De Wardener HE (1977) Natriuretic hormone. Clin Sci Mol Med 53: 1–8

    PubMed  Google Scholar 

  • De Wardener HD, Macgregor GA (1980) Dahl’s hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int 18: 1–9

    Article  PubMed  Google Scholar 

  • Falkner B, Onesti G, Angelakos ET, Fernandes M, Langman C (1979) Cardiovascular response to mental stress in normal adolescents with hypertensive parents. Hypertension 1: 23–30

    PubMed  CAS  Google Scholar 

  • Folkow B (1982) Physiological aspects of primary hypertension. Physiol Rev 62 (2): 347–503

    PubMed  CAS  Google Scholar 

  • Folkow B (1983) Personal views on the mechanisms of primary hypertension. In: Genest J, Kuchel O, Hamet P, Cantin M (eds) Hypertension: pathophysiology and treatment. McGraw-Hill, New York, pp 646–658

    Google Scholar 

  • Folkow B, Hallback-Nordlander M, Lundin S, Ricksten SE, Thoren P (1981) Neurogenic elements in rat primary hypertension-differences between SHR and MHS. In: Laragh JH (ed) Frontiers in hypertension research. Springer-Verlag, New York, pp 367–369

    Chapter  Google Scholar 

  • Freis ED (1960) Hemodynamics of hypertension. Physiol Rev 40: 27–54

    PubMed  CAS  Google Scholar 

  • Fröhlich ED (1977) Hemodynamics of hypertension. In Genest J, Koiw E, Kuchel O (eds) Hypertension. McGraw-Hill, New York, pp 15–48

    Google Scholar 

  • Genest J, Kuchel O, Hamet P, Cantin M (eds) (1983) Hypertension, 2nd edn. McGraw-Hill, New York

    Google Scholar 

  • Gross F (ed) (1977) Antihypertensive agents. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Gross FH, Robertson JIS (eds) (1979) Arterial hypertension. Pitman, London

    Google Scholar 

  • Gross F, Strasser T (eds) (1983) Mild hypertension. Recent advances. Raven, New York

    Google Scholar 

  • Guyton AC (1977) Personal views on mechanisms of hypertension. In: Genest J, Koiw E, Kuchel O (eds) Hypertension. McGraw-Hill, New York, pp 566–575

    Google Scholar 

  • Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Normal RA (1972) Arterial pressure regulation. Am J Med 52: 584–594

    Article  PubMed  CAS  Google Scholar 

  • Guyton AC, Coleman TG, Cowley AD JR, Manning RD JR, Norman RA JR, Ferguson JD (1974) A systems analysis approach to understanding long-range arterial blood pressure control and hypertension. Circ Res 35: 159–176.

    Google Scholar 

  • Hallback M, Folkow B (1974) Cardiovascular response to acute mental stress in spontaneously hypertensive rats. Acta Physiol Scand 90: 648–698

    Article  Google Scholar 

  • Halpern W, Mulvany NJ, Warshaw DW (1978) Mechanical properties of smooth muscle cells in the walls of arterial resistance vessels. J Physiol [Lond] 275: 85–101

    CAS  Google Scholar 

  • Hypertension Detection and Follow Up Cooperative Group I (1979) Reduction in mortality of persons with high blood pressure including mild hypertension. JAMA 242: 2562–2771

    Article  Google Scholar 

  • Judy WV, Watanabe AM, Henry DP, Besch HR, Murphy WR, Höckel KM (1976) Sympathetic nerve activity. Role in regulation of blood pressure in the spontaneously hypertensive rats. Circ Res 38 [Suppl II]: 21–29

    PubMed  CAS  Google Scholar 

  • Lardinois CL, Neuman SL (1988) The effects of antihypertensive agents on serum lipids and lipoproteins. Arch Intern Med 148: 1280–1286

    Article  PubMed  CAS  Google Scholar 

  • Ledingham JM, Cohen RC (1964) Changes in the extracellular fluid volume and cardiac output during the development of experimental renal hypertension. Can Med Assoc J 90: 292–294

    PubMed  CAS  Google Scholar 

  • Lindpaintner K, Takanashi S, Metzger R, Murakami K, Ganten D (1988) Restriction fragment length polymorphism (RFLP) of the renin gene distinguishes hypertensive and normotensive rat strains. Hypertension 12 (3): 359

    Google Scholar 

  • Lund-Johansen P (1967) Hemodynamics in early essential hypertension. Acta Med Scand 183 [Suppl 482]: 1–105

    Google Scholar 

  • Lund-Johansen P (1977) Hemodynamic alterations in hypertension-spontaneous changes and effects of drug therapy. A review. Acta Med Scand [Suppl] 603:l–14

    Google Scholar 

  • Lund-Johansen P (1980) Haemodynamics in essential hypertension. State of the art review. Clin Sci 59: 343s–354s

    PubMed  Google Scholar 

  • McCubbin JW, Green JH, Page IH (1956) Baroreceptor function in chronic renal hypertension. Circ Res 4: 205–210

    PubMed  CAS  Google Scholar 

  • Millar-Craig MW, Bishop CN, Raftery EB (1978) Circadian variation of blood pressure. Lancet 1: 795–797

    Article  PubMed  CAS  Google Scholar 

  • Multiple Risk Factor Intervention Trial Research Group (1982) Multiple risk factor intervention trial: risk factor changes and mortality results. JAMA 248: 1465–1477

    Article  Google Scholar 

  • Mulvany MJ, Hansen PK, Aalkjaer C (1978) Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrower lumen, a thicker media and a larger number of smooth muscle cell layers. Circ Res 43: 854–864

    PubMed  CAS  Google Scholar 

  • Page IH (ed) (1987) Hypertension mechanisms. Grune and Stratton, New York

    Google Scholar 

  • Pickering GW (1968) High blood pressure 2nd edn. Churchill, London

    Google Scholar 

  • Pickering GW (1977) Personal views on mechanisms of hypertension. In: Genest J, Koiw E, Kuchel O (eds) Hypertension. McGraw-Hill, New York, pp 598–606

    Google Scholar 

  • Rapp JP, Wand S-M, Dene H (1989) A genetic polymosphism in the renine gene of Dahl rats cosegregates with blood pressure. Science 243: 542–544

    Article  PubMed  CAS  Google Scholar 

  • Rascher W, Clough D, Ganten D (eds) (1982) Hypertensive mechanisms. Schattauer, Stuttgart

    Google Scholar 

  • Reid JL (1988) Hypertension 1988: present challenges and future strategies. J Hypertens 6: 3–8

    PubMed  CAS  Google Scholar 

  • Rettig R, Ganten D, Luft F (eds) (1989) Salt and hypertension. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Scriabine A (ed) (1980) Pharmacology of antihypertensive drugs. Raven, New York

    Google Scholar 

  • Sleight P (ed) (1980) Arterial baroreceptors and hypertension. Oxford Univ Press, London

    Google Scholar 

  • Strasser T, Ganten D (eds) (1987) Mild hypertension. From drug trials to practice. Raven, New York

    Google Scholar 

  • Suwa N, Takahashi T (1971) Morphological and morphometrical analysis of circulation in hypertension and ischemic kidney. Urban & Schwarzenberg, Berlin

    Google Scholar 

  • Thomas CB (1973) Genetic pattern of hypertension in man. In: Onesti G, Kim KE, Moyer JH (eds) Hypertension: mechanisms and management. Grune & Stratton, New York, pp 67–73

    Google Scholar 

Download references

Authors
  1. D. Ganten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. G. Mulrow
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. German Institute for High Blood Pressure Research and Department of Pharmacology, University of Heidelberg, Im Neuenheimer Feld 366, D-6900, Heidelberg, Germany

    Detlev Ganten M.D, Ph.D.

  2. Medical College of Ohio, CS10008, 300 Arlington Avenue, Toledo, OH, 43699, USA

    Patrick J. Mulrow M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ganten, D., Mulrow, P.G. (1990). Basis for the Treatment of Hypertension: Some Considerations Concerning the Epidemiology, Pathophysiology, Treatment, and Prevention of Hypertension. In: Ganten, D., Mulrow, P.J. (eds) Pharmacology of Antihypertensive Therapeutics. Handbook of Experimental Pharmacology, vol 93 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74209-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74209-5_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74211-8

  • Online ISBN: 978-3-642-74209-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation